Analysts Offer Insights on Healthcare Companies: Nanosonics Limited (OtherNNCSF) and Novavax (NVAX)
Analysts fell to the sidelines weighing in on Nanosonics Limited (NNCSF – Research Report) and Novavax (NVAX – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nanosonics Limited (NNCSF)
In a report released today, John Hester from Bell Potter upgraded Nanosonics Limited to Hold, with a price target of A$3.60. The company’s shares closed last Tuesday at $2.30.
According to TipRanks.com, Hester is a 4-star analyst with an average return of
Nanosonics Limited has an analyst consensus of Moderate Buy, with a price target consensus of $3.07, a 33.5% upside from current levels. In a report released today, TipRanks – OpenAI also downgraded the stock to Hold with a A$4.00 price target.
See today’s best-performing stocks on TipRanks >>
Novavax (NVAX)
In a report released today, Chris LoBianco from TD Cowen maintained a Hold rating on Novavax, with a price target of $8.00. The company’s shares closed last Tuesday at $9.46.
The word on The Street in general, suggests a Hold analyst consensus rating for Novavax with a $11.50 average price target.
